1. Kyle RA, Robinson RA, Katzmann JA et al. The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 1981; 71:999‑1008.
2. Campbell JP, J Heaney JL, Pandya S, Afzal Z et al.Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study .Lancet Haematol 2017;4:e584–94.
3. Pradhan D, Arora P, Gami A, Kaur N et.al.Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy. J Can Res Ther 2015; 11:660.
4. Wintrobe MM. Clinical Hematology. 8th ed. Philadelphia: Lea and Febiger; 1981. p. 1746.
5. Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113: 5412–17.
6. Mullikin TC, Rajkumar SV, Dispenzieri A, Buadi FK, Lacy MQ, Lin Y, et al. Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol. 2016 May; 91(5):473–5.
7. Juge-Morineau N, Heirman C, Bakkus M, Van Camp B, Malfait R, Harousseau JL, et al. Immunoglobulins D and M multiple myeloma variants are heavily mutated. Clinical Cancer Research. 1997;3(12):2501–06.
8. Franck P, Petitpain N, Guerci AP, Denisart S, Jacob C, Gueant JL et al.Myeloma with two monoclonal IgG and IgD in serum: a case report. Acta Haematologica. 1994; 92(3):144–47.
9. Tharp AM, Woodruff RD, Shihabi ZK. IgD-Kappa myeloma: an unusual case. Annals of Clinical and Laboratory Science. 2003;33(1):97–100.
10. Tschumper RC, Dispenzieri A, Abraham RS, Henderson KJ, Jelinek DF et al. Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies. Blood Cancer J 2013; 3: e112.
11. Lin P, Molina TJ, Cook JR, Swerdlow SH et al. Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation, TheAmerican Journal of Clinical Pathology, 2011;136(2)195–210.
12. Kriangkum J, Taylor BJ, Treon SP et al. Molecular characterization of Waldenstrom’s macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences, Clinical Cancer Research, 2007;13(7):2005–13.